T lymphocyte activation via dendritic cell-mediated antigen presentation

T lymphocyte activation via dendritic cell-mediated antigen presentation refers to the fundamental immunological process where dendritic cells (DCs) act as professional antigen-presenting cells (APCs) to initiate adaptive immune responses. DCs capture and process antigens into peptides, which are then displayed on Major Histocompatibility Complex (MHC) molecules for recognition by T-cell receptors (TCRs) (StatPearls, 2023). This interaction occurs within the immunological synapse and requires secondary co-stimulatory signals, such as the binding of CD80/CD86 on DCs to CD28 on T cells, to ensure robust activation rather than energy (Nature Reviews Immunology, 2018). In oncology, this pathway is exploited by dendritic cell vaccines like Sipuleucel-T to prime the immune system against tumor antigens, while checkpoint inhibitors modulate the signaling thresholds of this interaction to restore anti-tumor activity (NIH, 2022). Conversely, in autoimmune diseases, this process is targeted for inhibition to prevent the activation of self-reactive T cells. Because this term describes a complex multi-step cellular mechanism involving various receptors and ligands rather than a single protein, it is classified as a biological process or mechanism of action rather than a discrete molecular target.

Other names

Antigen presentationDC-T cell interactionImmunological synapseT cell primingDendritic cell-T cell axis

Modulation of the immunological synapse through antigen loading, co-stimulation enhancement, or checkpoint blockade to regulate T cell effector functions.